Zika virus (ZIKV) is an emerging virus transmitted by mosquitoes. It was first identified in Uganda in 1947 during routine monitoring of rhesus monkeys for jungle yellow fever. In 1952, it was identified in humans in Uganda and in the United Republic of Tanzania ([@B1]).

The Zika virus belongs to the *Flaviviridae* family. Other members of this family are the yellow fever virus, dengue virus, and Japanese encephalitis virus. Ribonucleic acid (RNA) viruses are transmitted by vectors, in this case by *Aedes aegypti, A. albopictus* ([@B2]), and other species of the genus *Aedes* ([@B3]). The Zika virus is characterized as a mild, dengue-like disease with fever, muscle aches, eye pain, prostration, and a maculopapular rash. In more than 60 years of observations, Zika has not been known to cause hemorrhagic fever or death ([@B3]).

In urban and suburban environments, the Zika virus is transmitted in a human--mosquito--human transmission cycle. The *Aedes* species is particularly difficult to control because it can reproduce in extremely small amounts of water. A large increase in ZIKV has been observed worldwide, whereas initially, it was endemic only in Africa and Asia. Cases have been reported in Europe, Oceania, and the Americas, particularly in Latin America, where it is rapidly spreading to new areas ([@B4]).

Zika virus infections were first detected in the Western Hemisphere in February 2014 on Chile\'s Easter Island. Cases were reported in northern Brazil that are suggestive of the presence of Zika in the Americas as early as October 2014, but infections were not detected and confirmed until May 2015 ([@B5]).

In January 2018, the Ministry of Public Health of Ecuador (MSP) reported that the total number of cases diagnosed in the country was 5 304 for the period from 2015 -- 2017. In 2016, in the province of Manabí, the number of cases reached 2 509, representing 85.2% of the total cases in the country ([@B6]). In Ecuador, there is a national strategy for controlling mosquito-borne diseases, with specific measures for reducing Zika cases ([@B7]).

Information on the ZIKV epidemic in Ecuador is limited, with few studies published in scientific journals. The MSP has published some information on its website regarding the disease.

The objective of this study was to estimate the number and percentage of cases with a Zika diagnosis at the Dr. Verdi Cevallos Balda Hospital during an outbreak of the disease in Portoviejo, Ecuador, in January -- August 2016.

MATERIALS AND METHODS
=====================

A hospital-based, retrospective, observational, descriptive, cross-sectional study was conducted to estimate the number and percentage of patients with Zika infection treated by the Dr. Verdi Cevallos Balda Hospital in Portoviejo, a small town in the province of Manabí, Ecuador. The data was extracted from a national surveillance database created by the MSP to gather information on epidemiological outbreaks. The laboratory of the National Institute of Public Health (a national reference laboratory in Ecuador) was responsible for conducting the molecular tests to confirm ZIKV. This work was reported with the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) checklist ([@B8]).

Patients and study design
-------------------------

A search was conducted of a database with information on patients treated in January -- August 2016 by the Dr. Verdi Cevallos Balda Hospital, the only public health system hospital in Portoviejo. The database included all patients who were treated at the hospital, regardless of age, sex, or other conditions, with symptoms related to contagious diseases; thus, there were no exclusion criteria. The case definition for this infection included one or more of the following symptoms: nonpurulent conjunctivitis, headache, pruritus, or arthralgia. For this analysis, cases included all patients who were reported to MSP with symptoms of ZIKV, with or without laboratory confirmation. Laboratory-confirmation was defined as the presence of clinical symptoms of Zika and a sample reactive by real-time reverse transcription polymerase chain reaction (rRT-PCR assay).

### Ethics

Authorization to obtain the data and to carry out this study was granted by the Ethics Committee of the Dr. Verdi Cevallos Balda Hospital. The study used a de-identified dataset to protect the confidentiality of the subjects.

Statistical analysis
--------------------

Categorical variables were expressed as counts and percentages, while continuous variables were presented as mean ± standard deviation (SD). The number of cases according to sex, age group, ethnicity, and type of medical care were analyzed. The number of pregnant women with Zika was calculated according to pregnancy trimester. The prevalence ratio was calculated with a 95% Confidence Interval (95%CI). The adjusted odds ratios (aORs) and 95%CIs were calculated using Mantel-Haenszel for associations of age, sex, and ethnicity (independent variables). For this calculation, the age variable was separated into two categories: \< 20 years of age and ≥ 20 years, taking into account that most suspected cases were among those ≥ 20. Additionally, ethnicity was grouped into two categories: mixed race (the country\'s main ethnic group comprised of European, Indigenous, Middle-Eastern, Asian and/or African ancestry) and other. For assessing the association between variables, Fisher\'s exact or chi-square tests were used. To compare the quantitative variables, the Student\'s T-test was used with the significance level fixed at 5%. Statistical analyses were performed using IBM SPSS Statistics software, version 24 (SPSS Inc., an IBM company, Chicago, Illinois, United States).

RESULTS
=======

From 1 January 2016 -- 31 August 2016, a total of 776 patients were treated by the hospital in Portoviejo, 96.3% of whom were from Portoviejo; the remainder was from districts near the city. Of the total, 467 (60.2%) were suspected cases of ZIKV disease, based on the presence of an acute onset rash with or without fever. Of the suspected cases, 148 (31.7%) were confirmed by the detection of ZIKV RNA through rRT-PCR. The rest of the subjects were diagnosed with dengue, chikungunya, or influenza, among other illnesses.

[Figure 1](#f1){ref-type="fig"} shows the evolution over time of the number of cases with an initial Zika diagnosis during the study period. An increase in Zika cases was observed from the first month of the study (January) to the last (August). The number of cases began to rise in April, with May and June seeing the highest numbers. A decrease was then observed from June through the end of the study period.

![Evolution over time of the number of suspected cases of Zika in Portoviejo, Ecuador, January -- August 2016](rpsp-42-e68-g001){#f1}

The majority of the included subjects were female (65.1%), and of these, only 35.2% had a laboratory confirmation of Zika; while for men, confirmation was 25.2%. Among patients with PCR reactive for Zika, women accounted for the majority.

Most of the patients were 20 -- 49 years of age (65.5%), followed by the group 15 -- 19 years of age. The initial diagnosis of Zika was less frequent in those ≥ 65 years. Regarding ethnicity, 99.9% of positive cases of Zika were within the mixed race group. Most patients affected by Zika were treated on an outpatient basis; only two patients required hospitalization. The group with other diagnoses exhibited similar behavior, but their PCR was non-reactive to ZIKV ([Table 1](#t1){ref-type="table"}).

###### Patients according to polymerase chain reaction (PCR) results for Zika and their main baseline characteristics, Portoviejo, Ecuador, January -- August 2016

  Patient characteristics   PCR for Zika    Total   *P* value[a](#TFN1){ref-type="table-fn"}                      
  ------------------------- --------------- ------- ------------------------------------------ ----- ------ ----- --------
  Gender                                                                                                          
                            Male            41      27.7                                       122   38.2   163   0.0163
                            Female          107     72.3                                       197   61.8   304   
  Group by age, in years                                                                                          
                            \< 1            2       1.4                                        15    4.7    17    
                            1 -- 4          5       3.4                                        34    10.7   39    
                            5 -- 9          8       5.4                                        31    9.7    39    0.0063
                            10--14          5       3.4                                        23    7.2    28    
                            15 -- 19        15      10.1                                       30    9.4    45    
                            20 -- 49        97      65.5                                       163   51.1   260   
                            50 -- 64        12      8.1                                        17    5.3    29    
                            ≥ 65            4       2.7                                        6     1.9    10    
  Ethnicity                                                                                                       
                            Indigenous      2       1.4                                        1     0.3    3     0.1689
                            Mixed race      140     94.6                                       313   98.1   453   
                            Not available   6       4.1                                        5     1.6    11    
                            Type of care                                                                          
                            Outpatients     146     98.6                                       310   97.1   456   0.1785
                            Hospitalized    2       1.4                                        9     2.9    11    

Source

: Prepared by the authors from the study results.

Chi square test for association (two tails).

A significant association was found between gender and age and ZIKV (*P* \< 5%). A higher proportion of female subjects was found to have a reactive PCR for Zika. With respect to age range, patients 20 -- 49 years and 50 -- 64 years were associated with positive cases of the virus. The frequency of patients according to ethnic group and type of care was similar between the two groups, with no association found (*P* ≥ 0.05).

The mean age of the 148 confirmed patients was 30 years ± 15 years, while the median age was 28, and the mode, 29 years. For those with a non-reactive PCR for Zika, the mean age was 25.5 years ± 16.7. The difference was statistically significant (Student\'s T test *P* = 0.00).

The associations between the independent variables and ZIKV are presented in [Table 2](#t2){ref-type="table"}. It was observed that the prevalence of Zika in women was higher than in men and higher among those ≥ 20 years of age. All the variables (gender, age, and ethnicity) in the model were significantly associated with Zika. Men were less likely to have the virus than women were (a0R = 0.62), and those \< 20 years of age appeared to be protected against the virus (a0R = 0.43). In both cases, *P* values were \< 0.05.

###### Association between the independent variables of the study (gender, age, and ethnicity) and the Zika virus, Portoviejo, Ecuador, January -- August 2016

  Predictive factors   Adjusted prevalence ratio   95% Confidence Interval   *P* value[a](#TFN2){ref-type="table-fn"}   Adjusted odds ratio   95% Confidence Interval   *P* value[a](#TFN2){ref-type="table-fn"}   
  -------------------- --------------------------- ------------------------- ------------------------------------------ --------------------- ------------------------- ------------------------------------------ --------
  Gender                                                                                                                                                                                                           
                       Female                      Ref                       Ref                                        Ref                   Ref                       Ref                                        Ref
                       Male                        0.72                      0.54 -- 0.97                               0.0312                0.62                      0.40 -- 0.95                               0.0263
  Age                                                                                                                                                                                                              
                       \< 20 years                 Ref                       Ref                                        Ref                   Ref                       Ref                                        Ref
                       ≥ 20 years                  0.66                      0.47 -- 0.91                               0.0118                0.43                      0.26 -- 0.67                               0.0126
  Ethnicity                                                                                                                                                                                                        
                       Mixed race                  Ref                       Ref                                        Ref                   Ref                       Ref                                        Ref
                       Other                       0.74                      0.45 -- 1.00                               0.2478                0.38                      0.17 -- 0.88                               0.0145

Source

: Prepared by the authors from the study results.

Mantel-Haenszel test.

An average of 3.3 days (± 0.98 days) passed from the onset of symptoms to the date of being treated at the hospital. Three patients were excluded from the analysis as outliers at 12, 15, and 26 days. The main symptoms were elevated body temperature, maculopapular rash that often extended from the face to the body, arthritis or arthralgia with transient inflammation of joints (especially in the small joints of the hands and feet), and conjunctival hyperemia. Other non-specific symptoms, such as myalgia, fatigue, and headache were also common. None of the patients had a vaccination history or known comorbidities. It should also be noted that all the cases studied were autochthonous.

The duration of symptoms ranged from 2 -- 7 days, with a mean of 4.5 days (± 1.8 days). No deaths or neurologic complications following the Zika virus infection occurred among the patients studied.

Of the 265 women of childbearing age (15 -- 49 years), 110 were pregnant; of these, only 33 had a confirmation of Zika by PCR. Of the 33 pregnant women with Zika, 61% were in their second trimester, while 39% were in the first. At the time of this report, most of these pregnancies were still ongoing. There was a nonsignificant statistical association between the age of the pregnant woman and the virus ([Table 3](#t3){ref-type="table"}).

###### Pregnant women according to age group and results of to polymerase chain reaction (PCR), Portoviejo, Ecuador, January -- August 2016

  Age group        PCR reactive   PCR non-reactive   Total   *P* value[a](#TFN3){ref-type="table-fn"}                 
  ---------------- -------------- ------------------ ------- ------------------------------------------ ----- ------- ------
  15 -- 19 years   8              36.0               14      64.0                                       22    20.0    
  20 -- 49 years   25             28.4               63      71.6                                       88    80.0    0.60
  Total            33             30.0               77      70.0                                       110   100.0   

Source

: Prepared by the authors from the study results.

Fisher exact test.

DISCUSSION
==========

This study is the first to report data concerning the percentage of positive cases of Zika in a hospital in the city of Portoviejo, Ecuador. Of the suspected cases, 31.7% were positive for ZIKV as confirmed by PCR.

The peak number of ZIKV cases was observed in June 2016 during the rainy season, concurring with the weather patterns found in previous outbreaks in Brazil ([@B9]). In the Portoviejo area, the rainy season runs from December to mid-May, but heavy rains may occur frequently throughout the year. The proliferation of stagnant water, plus the impact of the earthquake that occurred along the Pacific coast in Ecuador on 16 April 2016, increased the risk of vector transmission, possibly causing the rise in Zika cases. In 2017, the percentage of cases decreased dramatically in the same area, from 85.2% to 35.4% ([@B6]).

The study results showed that men were less likely to get Zika than women, as were people under 20 years of age. A study conducted in Brazil by Coelho and colleagues demonstrated that the incidence of Zika is higher among women and those 15 -- 65 years age ([@B10]). In another study performed in Brazil, the age distribution of confirmed ZIKV cases suggested a higher proportion of cases in individuals from 20 -- 50 years of age ([@B9]), a pattern very similar to the one observed by our study.

Zika virus usually presents with mild symptoms that may go unnoticed or be misdiagnosed as dengue, chikungunya, or other viral diseases that cause fever and rash. These diseases are also common in Manabí, which is why the percentage of patients with other diagnoses in our study was very high. In most cases, symptoms were treated and very few hospitalizations were required.

According to a study of Zika in pregnancy ([@B11]), pregnant women do not differ from other population groups in terms of the frequency of complications. However, the virus has a high affinity for nerve tissue, so the central and peripheral nervous systems of both mother and fetus can be compromised to varying degrees, depending on viral virulence, viral load, susceptibility, and personal immune response ([@B11]). The results of our study are consistent with this statement.

Due to the high number of pregnant women in our study, the hospital has established a system of close monitoring for these pregnancies. Fetal abnormalities have been reported in pregnant women with the Zika ([@B12]), but at the time of this study, the hospital\'s epidemiology department had not reported any cases of microcephaly or other adverse neonatal outcomes. However, for the period 2015 -- 2017, there were four cases of microcephaly reported in Manabí ([@B6]), probably occurring after our study period. Zambrano and colleagues reported two cases of microcephaly linked to ZIKV in Guayaquil, a city located in another province of Ecuador ([@B13]).

A case control study performed in coastal Ecuador ([@B14]), including Manabí, reported that the incidence of ZIKV among the general population and in pregnant women rose after the earthquake of April 2016. At the national level, in 2015 -- 2017, Ecuador reported 959 cases of Zika in pregnant women: 134 cases in pregnant women with a gestational age of \< 12 weeks, 417 cases with a gestational age ≥ 12 weeks, and 166 cases with a gestational age ≥ 28 weeks ([@B6]). In 2016, there were 242 reported cases of Zika among pregnant women in all of Ecuador.

This study corroborates previously published reports suggesting that the clinical course of the Zika virus is typically mild in adults ([@B15]).

### Limitations

This study is the first to report data on Zika prevalence in the city of Portoviejo, Ecuador. It is limited to one particular situation in a single hospital in just one city; it does not reflect the reality of the entire country. The study design would have been stronger if it had been integrated with a simultaneous entomological survey of the study area. Another limitation is that the study used secondary data, which may not be accurate. Also, the data were not collected to answer a research question, but rather as part of the MSP surveillance system.

Conclusions
-----------

This work was the first to investigate the characteristics of the Zika epidemic in Portoviejo; it reviews some data about epidemiological characteristics of the disease and possible associations with risk factors. The percentage of confirmed cases reached one-third of the study population. The disease was more likely to occur in women and in subjects over 20 years of age, stressing the importance of surveillance of this group to avoid transmission of Zika to newborns. The number of infected pregnant women was an important finding that could be used as an indicator to help determine the risk of complications from Zika in infants.

Authorities at the hospital and the Ministry of Public Health are working hard to diminish the high number of suspected cases of Zika and are giving special attention to pregnant women. However, there are still many questions to be answered in relation to the presence of Zika virus in Ecuador. Future studies are recommended for addressing the research gap and to inform national Zika control efforts.
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